Literature DB >> 21139600

New twists on proteasome inhibitors.

Jim Kling.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21139600     DOI： 10.1038/nbt.1727

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

Review 1.  The development of proteasome inhibitors as anticancer drugs.

Authors:  Julian Adams
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

2.  Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors.

Authors:  Holger Rumpold; Christina Salvador; Anna Maria Wolf; Herbert Tilg; Guenther Gastl; Dominik Wolf
Journal:  Biochem Biophys Res Commun       Date:  2007-07-23       Impact factor: 3.575

3.  An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.

Authors:  Stephen Orlicky; Xiaojing Tang; Victor Neduva; Nadine Elowe; Eric D Brown; Frank Sicheri; Mike Tyers
Journal:  Nat Biotechnol       Date:  2010-06-27       Impact factor: 54.908

4.  Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans.

Authors:  Sanford Levine; Taitan Nguyen; Nyali Taylor; Michael E Friscia; Murat T Budak; Pamela Rothenberg; Jianliang Zhu; Rajeev Sachdeva; Seema Sonnad; Larry R Kaiser; Neal A Rubinstein; Scott K Powers; Joseph B Shrager
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245
  4 in total
  4 in total

1.  Next-generation proteasome inhibitor approved in multiple myeloma.

Authors:  Alla Katsnelson
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

2.  Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.

Authors:  Céline Jacquemont; Julian A Simon; Alan D D'Andrea; Toshiyasu Taniguchi
Journal:  Mol Cancer       Date:  2012-04-26       Impact factor: 27.401

3.  Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast.

Authors:  Laura Gatti; Kwang L Hoe; Jacqueline Hayles; Sabina C Righetti; Nives Carenini; Laura Dal Bo; Dong U Kim; Han O Park; Paola Perego
Journal:  BMC Genomics       Date:  2011-01-19       Impact factor: 3.969

4.  Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination.

Authors:  Xin Zhang; Ran Xu; Chao Zhang; Yangyang Xu; Mingzhi Han; Bin Huang; Anjing Chen; Chen Qiu; Frits Thorsen; Lars Prestegarden; Rolf Bjerkvig; Jian Wang; Xingang Li
Journal:  J Exp Clin Cancer Res       Date:  2017-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.